Page last updated: 2024-11-05

tranexamic acid and Experimental Hepatoma

tranexamic acid has been researched along with Experimental Hepatoma in 2 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research Excerpts

ExcerptRelevanceReference
"The fibrinolytic inhibitor tranexamic acid affects certain experimental tumours; it prolongs survival (Lewis lung adenocarcinoma), decreases tumour weight (C3H breast carcinoma), and inhibits ascitic production (AH 130 rat hepatoma)."3.66Effect of tranexamic acid on progress of experimental tumours and on DNA-synthesis. ( Astedt, B; Tropé, C, 1980)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dutta, S1
Park, JA1
Jung, JC1
Chang, Y1
Kim, TJ1
Astedt, B1
Tropé, C1

Other Studies

2 other studies available for tranexamic acid and Experimental Hepatoma

ArticleYear
Gd-complexes of DTPA-bis(amide) conjugates of tranexamic acid and its esters with high relaxivity and stability for magnetic resonance imaging.
    Dalton transactions (Cambridge, England : 2003), 2008, Apr-28, Issue:16

    Topics: Amides; Animals; Cell Line; Cell Survival; Chick Embryo; Contrast Media; Cornea; Drug Stability; Est

2008
Effect of tranexamic acid on progress of experimental tumours and on DNA-synthesis.
    Experientia, 1980, Jun-15, Volume: 36, Issue:6

    Topics: Adenocarcinoma; Animals; Cyclohexanecarboxylic Acids; DNA, Neoplasm; Liver Neoplasms, Experimental;

1980